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In this issue, De Bari et al. (2003) present elegant data to
counter the recent claims that adult stem cells have a limited
plasticity. Further, they provide evidence that adult stem
cells can seek out damaged tissues and repair them.
 
De Bari et al. (2001) previously demonstrated that mesen-
chymal stem cells from human synovial membranes (hSM-
MSCs)* are similar to the adult stem cells originally isolated
from bone marrow and referred to as mesenchymal stem
cells or marrow stromal cells (MSCs) (Friedenstein et al.,
1976; Caplan, 1991; Prockop, 1997) and also to stem cells
isolated from other tissues (for review see Sanchez-Ramos,
2002). hSM-MSCs, like other MSCs, can be expanded ex-
tensively without loss of multipotentiality. Hence, they have
potential advantages for therapy over myoblasts that expand
poorly in culture and rapidly undergo senescence.
In their current work, De Bari et al. (2003) infused hSM-
MSCs into the tibialis anterior muscle of nude mice after
muscle damage by infusion of cardiotoxin. They found that
 
 
 
10% of the infused human cells were present in the muscle
after 1 d and that about twice as many were present after 1
mo, demonstrating that the cells both engrafted and ex-
panded in the tissue. They also showed that the engrafted
human cells differentiated into muscle cells. Similar results
were obtained when hSM-MSCs were infused intravenously;
however, without prior damage to the muscle, the degree of
engraftment was lower but still detectable. Some of the human
cells engrafted as muscle satellite cells that, remarkably, 6 mo
after their appearance, could be activated to differentiate
into muscle by administration of cardiotoxin.
In experiments with the mdx mouse model for muscular
dystrophy, infusion of the hSM-MSCs into muscle induced
synthesis of human dystrophin. It also decreased the number
of centronucleated fibers, a pathological feature of dystrophic
mdx muscle. Most importantly, infusion of the hSM-MSCs
restored the synthesis of mechano growth factor, a protein
that controls repair of normal muscle and that undergoes
deregulation in mdx muscle. In contrast, infusion of a plasmid
containing the dystrophin gene produced synthesis of dys-
trophin but did not rescue expression of the mechano
growth factor. Therefore, as the authors suggest, the results
are encouraging for current efforts to develop hSM-MSCs or
related cells for the potential therapy of muscular dystrophy.
One frequent criticism of papers describing plasticity of
adult stem cells is that the preparations of cells were hetero-
geneous. Therefore, the apparent plasticity could be explained
by selection for subpopulations already committed to differ-
entiation to specific phenotypes. In practice, MSCs and similar
cells from other tissues are among the easiest mammalian
cells to clone. Since the earliest work of Friedenstein et al.
(1976), a standard assay for MSCs from bone marrow has
been to plate the cells at very low densities and count the
single cell–generated colonies as a measure of the quality of
the cells. De Bari et al. (2003) took care to demonstrate that
the results they obtained with clonal hSM-MSCs were the
same as those obtained with unfractionated cells.
Another criticism of reports on the plasticity of adult stem
cells has been that many of the observations can be explained
by cell fusion (Terada et al., 2002; Ying et al., 2002). As
expected, De Bari et al. (2003) saw cell fusion in their exper-
iments since myogenesis normally proceeds by fusion of
myoblasts into multinucleated myotubes. However, they
performed careful time course experiments to demonstrate
that they did not detect muscle fibers containing human nuclei
until day 7 after the infusions. After only 24 h, however,
there was a sharp peak in expression of human Myf5, a factor
that restricts undifferentiated cells to myogenesis. Therefore,
they concluded that after infusion of the hSM-MSCs they
were observing a multistep process in which the cells prolif-
erated, became committed to a myogenic lineage, and then
underwent final maturation and fusion.
This report comes in the midst of a current controversy
over adult stem cells. The controversy has been fanned by
the continuing ethical and political debate about restrictions
on research with human embryonic stem cells. At the heart
of the scientific controversy, however, is the difficulty of
standardizing preparations of nonhematopoietic adult stem
cells and of developing adequate in vivo assays. In effect,
there is no animal test model comparable to the marrow-
ablated mouse that has been the key to research on hemato-
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poietic stem cells. Experiments in vivo are simple in concept
but remarkably complex in practice. For example, recent ob-
servations (Terada et al., 2002; Ying et al., 2002) suggest
that cell fusion may explain previous experiments in which
stem cells from adult brain were used with embryonic stem
cells to produce chimeric animals (Clarke et al., 2000).
However, the observations on cell fusion by stem cells raise
interesting questions about the role of cell fusion in differen-
tiation and repair. We (Spees et al., 2003) recently observed
that cell fusion was a relatively frequent event in an ex vivo
model for tissue repair in which MSCs were cocultured with
heat-shocked pulmonary epithelial cells.
The complexity of assaying nonhematopoietic adult stem
cells in vivo is further illustrated by the surprising discrepan-
cies in published data. In experiments in which marrow-
derived cells were infused into mice, some investigators re-
ported trace (Krause et al., 2001) or undetectable levels
(Castro et al., 2002;
 
 
 
Wagers et al., 2002) of engraftment
into nonhematopoietic tissues. Others found relatively high
levels of engraftment. For example, we (Pereira et al., 1998)
reported that progeny of donor MSCs accounted for 5% or
more of the cells in many tissues after infusion of the cells
into young mice that were x ray irradiated. More recently,
LaBarge and Blau (2002) found that bone marrow cells con-
tributed to as many as 3.5% of muscle fibers after the mus-
cles of mice were damaged by irradiation and exercise. De-
vine et al. (2002) reported that after GFP-transduced MSCs
were infused into lethally irradiated baboons, progeny of the
MSCs accounted for 0.1–2.7% of the cells in most nonhe-
matopoietic tissues. Some of the discrepancies are probably
explained by loss of the labels used to mark the cells as the
cells differentiate and proliferate. However, the critical prob-
lems are clearly the cell populations used for the experiments
and the status of the recipient animals in terms of variables
such as age and the presence of tissue injury. For example,
although clonal colonies of MSCs and related cells are
readily prepared, the colonies rapidly become heterogeneous
as they expand so that they contain subpopulations of early
progenitors and more differentiated cells. The early progeni-
tors are quickly lost during expansion unless the cells are
maintained at very low densities and the culture conditions
carefully monitored (Sekiya et al., 2002). It has not been es-
tablished, however, which subpopulations provide the most
robust engraftment and differentiation. Until these variables
are defined, it is very likely that large discrepancies will con-
tinue to be observed in similar experiments performed by
different investigators.
At the same time, the results of De Bari et al. (2003) add
to the growing body of evidence demonstrating that stem-
like cells can be obtained from a variety of tissues and that
these cells have the remarkable ability to migrate to sites of
tissue damage and stimulate repair either by differentiating
into tissue-specific cells or, alternatively, by creating a milieu
that enhances the repair of endogenous cells (Hofstetter et
al., 2002; Li et al., 2002). The hypothesis that such stem-
like cells take part in normal tissue repair is long-standing
(Cohnheim, 1867; Prockop, 1997). The last vestiges of
doubt about it have probably been erased by recent evidence
from patients who have received sex-mismatched transplants
of bone marrow or organs. In one study, 4–40% of the
hepatocytes and cholangiocytes in liver were derived from
donor bone marrow (Theise et al., 2000). In another study,
1–2% of the cardiomyocytes in transplanted donor hearts
were host cells (Bayes-Genis et al., 2002). With better assays
for adult stem cells, it should be possible to improve on the
encouraging preliminary results that been obtained in clini-
cal trials with MSCs in osteogenesis imperfecta (Horwitz et
al., 2001) and in metachromatic leukodystrophy and Hurler
syndrome (Koc et al., 2002).
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